[{"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96380", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0269-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10", "product_quantity": "11,100 bottles.", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250228", "center_classification_date": "20250311", "report_date": "20250319", "code_info": "Lot#: 240301C, Expiration: 01/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Rochester", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96013", "recalling_firm": "ENDO USA, Inc.", "address_1": "870 Parkdale Rd", "address_2": "", "postal_code": "48307-1740", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA nationwide.", "recall_number": "D-0223-2025", "product_description": "Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103-01", "product_quantity": "44,397 amber glass vials", "reason_for_recall": "Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin\u00bf (epinephrine injection, USP)", "recall_initiation_date": "20241220", "center_classification_date": "20250205", "report_date": "20250212", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95853", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0162-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.", "product_quantity": "76,968 bottles", "reason_for_recall": "CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot #  230077C, exp. date 11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95993", "recalling_firm": "Hikma Injectables USA Inc", "address_1": "36 Stults Rd", "address_2": "", "postal_code": "08810-1540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0173-2025", "product_description": "ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25", "product_quantity": "1,800 syringes", "reason_for_recall": "Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.", "recall_initiation_date": "20241219", "center_classification_date": "20250102", "termination_date": "20251112", "report_date": "20250108", "code_info": "Lot number: 242560008D, Use by Date 01/15/2025; 242970002D, Use by Date 02/25/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200770"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-328"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905395"], "spl_id": ["2a320d81-424b-f045-e063-6294a90ac1ac"], "spl_set_id": ["faaf3493-8318-48b3-b59c-03537880744b"], "package_ndc": ["63739-328-10", "0000127410", "0000127579", "0000128245", "0000128486"], "original_packager_product_ndc": ["64380-735"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "96159", "recalling_firm": "SKY PACKAGING", "address_1": "4835 Crumpler Rd Ste B", "address_2": "", "postal_code": "38141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0220-2025", "product_description": "HydrALAZINE Hydrochloride, 100 Tablets (10x10), USP, 50mg, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-328-10", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250124", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot #: 0000127410, 63739-328-10, Exp. Date 30-Apr-2025; 0000127579, Exp. Date 31-Aug-2025; 0000128245, Exp. Date 31-Dec-2025; 0000128486, Exp. Date 28-Feb-2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02", "49884-310-52"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "95778", "recalling_firm": "Endo USA, Inc.", "address_1": "1400 Atwater Dr", "address_2": "", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0178-2025", "product_description": "Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV, Rx Only, 60 Tablets per carton, 10 blister cards containing 6 tablets each, Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-310-02 (carton), NDC#: 49884-310-52 (blisters).", "product_quantity": "9,816 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.", "recall_initiation_date": "20241118", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot # 550176501, 550176601, Exp 02/28/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215037"], "brand_name": ["NELARABINE"], "generic_name": ["NELARABINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1839"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NELARABINE"], "rxcui": ["603566"], "spl_id": ["a144ddba-18cc-441e-942e-4170b34d4a3e"], "spl_set_id": ["8cb23281-93ca-40b8-b8e0-c57dd4298322"], "package_ndc": ["70710-1839-1", "70710-1839-8"], "is_original_packager": [true], "upc": ["0370710183912"], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["60158CV180"]}, "product_type": "Drugs", "event_id": "96291", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0256-2025", "product_description": "Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1839-1;  b) 6 x 50 mL Single-Dose Vial, NDC 70710-1839-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ", "product_quantity": "1,893 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250213", "center_classification_date": "20250306", "report_date": "20250312", "code_info": "Lot: a) P300197, Exp. Aug-2025; P400113, Exp. May-26;  b) P300169, Exp. Jun-2025; P400115, Exp. May-2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0234-2025", "product_description": "Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-268-30.", "product_quantity": "190,320 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234109, Exp.: 9/2025; 19234897, Exp.: 11/2025; 19240501, Exp.: 1/2026; 19241489, Exp.: 3/2026; 19241806, Exp.: 4/2026."}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209313"], "brand_name": ["METFORMIN ER 500 MG"], "generic_name": ["METFORMIN ER 500 MG"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "product_ndc": ["82009-117", "82009-118"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["ff196435-14d6-8b9d-e053-6294a90a4ee8"], "spl_set_id": ["ff196435-14f4-8b9d-e053-6294a90a4ee8"], "package_ndc": ["82009-117-10", "82009-118-01"], "is_original_packager": [true], "upc": ["0382009118017", "0382009117102"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "96082", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributor in OH.", "recall_number": "D-0192-2025", "product_description": "Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000-count bottles, Rx Only, Manufactured by: Granules India Limited, Hyderabad- 500 081, India, Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Grand Cayman Islands, NDC 82009-117-10", "product_quantity": "6,804 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "Lot #: 4911311A, Exp. Date: 11/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0254-2025", "product_description": "Morphine Sulfate 5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Solution, Rx Only, Mfg by: Hikma, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00406800312, b) 00406800330, c) 00054051750.", "product_quantity": "12390 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #s:  a) 24220672, Exp 02/19/2025; 24280145, Exp 03/18/2025; 24240711, Exp 03/19/2025; b) 24180729, Exp 01/23/2025; 25030427, Exp 07/17/2025;  c) 24360865, 24360864, Exp 03/31/2025; 24480235, Exp 06/21/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02", "49884-307-52"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "95778", "recalling_firm": "Endo USA, Inc.", "address_1": "1400 Atwater Dr", "address_2": "", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0180-2025", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-307-02 (carton), NDC #: 49884-307-52 (blisters).", "product_quantity": "72,973 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.", "recall_initiation_date": "20241118", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot #s: 550142801, 550142901, 550143001, 550143101, 550143201, 550143301, 550143401, 550147201, 550147401, Exp. 08/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Brampton", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96395", "recalling_firm": "Sigan Industries Group Inc.", "address_1": "296 Orenda Rd", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0274-2025", "product_description": "Walgreens, Acne Control Cleanser, 10% Benzoyl Peroxide/Acne Treatment, NET WT 5 OZ (142g) Distributed by: Walgreen CO, 200 Wilmont RD, Deerfield, IL, Made in Canada. UPC#: 1 9560203602 8", "product_quantity": "13,440 tubes", "reason_for_recall": "Chemical Contamination: Presence of benzene", "recall_initiation_date": "20250228", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "Lot#: 23-09328, Exp.: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dover Plains", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96001", "recalling_firm": "GNMart LLC", "address_1": "7 Sawmill Ln", "address_2": "", "postal_code": "12522-6086", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0170-2025", "product_description": "FORCE FOREVER 400mg Tablets, Huesos y articulaciones sin dolor, SUPLEMENTO ALIMENTICIO, 60-count bottles", "product_quantity": "374 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA. FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.", "recall_initiation_date": "20241212", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "All lots, Exp. Date: 03/27/2030", "more_code_info": ""}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0264-2025", "product_description": "Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle", "product_quantity": "150.0 gm", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HALAC0010123, exp. date Dec-2026 HALAC0050923, exp. date Aug-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0251-2025", "product_description": "Simethicone 20 mg per 0.3 mL Oral Syringe, Delivers: 0.3 mL, Oral Drops, Mfg By: Rugby, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 00536130375.", "product_quantity": "10992 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #s: 24201295, Exp 02/05/2025; 24210364, Exp 02/20/2025; 24231720, Exp 02/27/2025; 24500770, Exp 06/26/2025; 24471182, Exp 06/20/2025; 25031031, Exp 07/22/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020161"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-7074", "0990-7075", "0990-7077"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312507", "1860239", "1860241", "1860463", "1860466"], "spl_id": ["88bcbbe4-9ebf-4491-874a-c4c4c7f1f90d"], "spl_set_id": ["eb56a807-ea94-4edb-9811-a04b19568468"], "package_ndc": ["0990-7074-26", "0990-7075-14", "0990-7075-26", "0990-7077-14", "0990-7077-26", "0030990707", "3030990707"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96250", "recalling_firm": "ICU Medical, Inc.", "address_1": "600 N Field Dr", "address_2": "", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0267-2025", "product_description": "POTASSIUM CHLORIDE Inj., 20 mEq total in 100 mL flexible container 24 x case, 200 mEq/L, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7075-26; Bar Code Flexible container (01) 00309907075266; Case (01)30309907075267", "product_quantity": "67,488 flexible containers", "reason_for_recall": "Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling affixed to the product flexible container.", "recall_initiation_date": "20250213", "center_classification_date": "20250310", "report_date": "20250319", "code_info": "Lot 1023172, Exp Date: 31 January 2026", "more_code_info": ""}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95993", "recalling_firm": "Hikma Injectables USA Inc", "address_1": "36 Stults Rd", "address_2": "", "postal_code": "08810-1540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0174-2025", "product_description": "phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25", "product_quantity": "", "reason_for_recall": "Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.", "recall_initiation_date": "20241219", "center_classification_date": "20250102", "termination_date": "20251112", "report_date": "20250108", "code_info": "Lot number: 243120003D, Use by Date: 03/11/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202910"], "brand_name": ["IRBESARTAN"], "generic_name": ["IRBESARTAN"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-441", "50268-440", "50268-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IRBESARTAN"], "rxcui": ["200094", "200095", "200096"], "spl_id": ["3c1c8771-3bbc-7b5a-e063-6394a90a192c"], "spl_set_id": ["61b60f94-35e6-b90b-08ce-fbb2fe011f34"], "package_ndc": ["50268-440-11", "50268-440-15", "50268-441-11", "50268-441-15", "50268-442-11", "50268-442-15"], "original_packager_product_ndc": ["31722-729", "31722-730", "31722-731"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["J0E2756Z7N"]}, "product_type": "Drugs", "event_id": "96172", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0224-2025", "product_description": "Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15", "product_quantity": "341 cartons", "reason_for_recall": "Out of Specification for Dissolution", "recall_initiation_date": "20250121", "center_classification_date": "20250211", "report_date": "20250219", "code_info": "Lot 45279, Exp 03/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Northbrook", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA204096"], "brand_name": ["ASTAGRAF XL"], "generic_name": ["TACROLIMUS EXTENDED-RELEASE CAPSULES"], "manufacturer_name": ["Astellas Pharma US, Inc."], "product_ndc": ["0469-0647", "0469-0677", "0469-0687"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["1431971", "1431977", "1431980", "1431982", "1431985", "1431987"], "spl_id": ["15be9383-263f-4080-bda4-2ab0bdfbf239"], "spl_set_id": ["550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e"], "package_ndc": ["0469-0647-73", "0469-0647-11", "0469-0677-73", "0469-0677-11", "0469-0687-73", "0469-0687-11"], "is_original_packager": [true], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "96008", "recalling_firm": "Astellas Pharma US Inc.", "address_1": "2375 Waterview Dr", "address_2": "", "postal_code": "60062-6145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0210-2025", "product_description": "Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.", "product_quantity": "3,500 30-count bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules", "recall_initiation_date": "20241223", "center_classification_date": "20250129", "report_date": "20250205", "code_info": "Lot# 0R3092A, EXP 03/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96428", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0290-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.", "product_quantity": "347 Cartons", "reason_for_recall": "Super-Potent Drug: Out of specification potency results were obtained.", "recall_initiation_date": "20250307", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "Lot 3116074, Exp. 09/30/2025"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96074", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0189-2025", "product_description": "Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60", "product_quantity": "73,680 bottles", "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "Lot # DT2023003A, DT2023007A, DT2023008A, exp. date Jan-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210207"], "brand_name": ["CINACALCET HYDROCHLORIDE"], "generic_name": ["CINACALCET HYDROCHLORIDE"], "manufacturer_name": ["Slate Run Pharmaceuticals"], "product_ndc": ["70436-007", "70436-008", "70436-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["bd9ce3c3-15d0-454a-8546-58fa06c3bea7"], "spl_set_id": ["0850ec78-ae46-481e-a6b5-8169cb843eab"], "package_ndc": ["70436-007-04", "70436-008-04", "70436-009-04"], "is_original_packager": [true], "upc": ["0370436009046"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "96433", "recalling_firm": "Slate Run Pharmaceuticals", "address_1": "277 W Nationwide Blvd Ste 260", "address_2": "N/A", "postal_code": "43215-0169", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 8 distributors who may have further distribute the product nationwide.", "recall_number": "D-0278-2025", "product_description": "Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04", "product_quantity": "56,790 bottles", "reason_for_recall": "CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.", "recall_initiation_date": "20250307", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078203"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6007", "0904-6008", "0904-6009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LORAZEPAM"], "rxcui": ["197900", "197901", "197902"], "spl_id": ["6b6c2fbc-d12d-41d7-b49d-cf374c773cbd"], "spl_set_id": ["62f6eb3b-813d-4890-aca9-799b7fa890df"], "package_ndc": ["0904-6007-60", "0904-6007-61", "0904-6008-60", "0904-6008-61", "0904-6009-60", "0904-6009-61"], "original_packager_product_ndc": ["69315-904", "69315-905", "69315-906"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "96151", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide U.S. and Puerto rico", "recall_number": "D-0228-2025", "product_description": "Lorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-906 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6009-61.", "product_quantity": "27,525 cartons", "reason_for_recall": "Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.", "recall_initiation_date": "20250121", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot #s: N01422, N01423, Exp 03/31/2025; N01661, N01662, Exp 09/30/2025; N01746, N01750, Exp 10/31/2025; N01876, N01877, Exp 03/31/2026; N01899, N01900, N01975, Exp 04/30/2026."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0238-2025", "product_description": "Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-755-01.", "product_quantity": "120,000 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers:  19232356, Exp.: 5/2025; 19233198, Exp.: 7/2025; 19234213, 19234232, Exp.: 9/2025; 19241445, Exp.: 3/2026; 19243033, 19243121, Exp.: 7/2026."}, {"status": "Ongoing", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205927"], "brand_name": ["PRASUGREL"], "generic_name": ["PRASUGREL"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["51407-444", "51407-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRASUGREL HYDROCHLORIDE"], "rxcui": ["855812", "855818"], "spl_id": ["20262c39-020c-b649-e063-6294a90a2d9f"], "spl_set_id": ["bb78f952-69a5-1620-e053-2a95a90afe97"], "package_ndc": ["51407-444-30", "51407-445-30"], "original_packager_product_ndc": ["0378-5185", "0378-5186"], "unii": ["G89JQ59I13"]}, "product_type": "Drugs", "event_id": "96441", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0287-2025", "product_description": "PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30", "product_quantity": "2,601 30-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250305", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "Lot no's: GS059908, GS060228, GS060709, GS061233, GS061704, GS062158, GS062405, Exp.: 04/30/2026"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217791"], "brand_name": ["ATROPINE SULFATE"], "generic_name": ["ATROPINE SULFATE MONOHYDRATE"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-716"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["ATROPINE SULFATE"], "rxcui": ["1190655"], "spl_id": ["07ece291-b401-4c28-9c81-6b686aa36e07"], "spl_set_id": ["bfdb85b2-86d0-4f32-a8fa-272af48a191c"], "package_ndc": ["70069-716-01"], "is_original_packager": [true], "upc": ["0370069716014"], "unii": ["03J5ZE7KA5"]}, "product_type": "Drugs", "event_id": "95997", "recalling_firm": "SOMERSET THERAPEUTICS LLC", "address_1": "300 Franklin Square Dr", "address_2": "", "postal_code": "08873-4187", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0169-2025", "product_description": "Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01", "product_quantity": "5,870 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20241216", "center_classification_date": "20241231", "termination_date": "20250610", "report_date": "20250108", "code_info": "Lot #: A240211, Exp. Date April 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Racine", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96324", "recalling_firm": "Johnson, S C and Son, Inc", "address_1": "1525 Howe St", "address_2": "", "postal_code": "53403-2237", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States and Canada", "recall_number": "D-0275-2025", "product_description": "Kids by babyganics SPF 50 totally tropical (titanium dioxide 3/5%, zinc oxide 7.25%) packaged in a) 6 OZ (170 g) spray bottles UPC 813277019954 and UPC 813277019800; and b) Twinpack UPC 813277019930; Dist. by KAS Direct LLC, 1525 Howe St. Racine, WI 53403.", "product_quantity": "449,502 units", "reason_for_recall": "Chemical Contamination", "recall_initiation_date": "20250213", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "a) UPC 813277019954  Lot #: A034 / 5810343A, A034 / 5820343A, Exp. Date Feb-25; A282 / 0122853A,  A289 / 0132853A, Exp. Date Oct-25; C010 / 1680174A, C011 / 1690174A, Exp. Date Jan-26;  C218 / 2592224A, C218 / 2602224A, Exp. Date Aug-26.  UPC 813277019800 Lot #: A142 / 3901443A, A142 / 3911443A, A142 / 3921443A, Exp. Date May-25; A278 / 0142843A, A279 / 0152843A, A279 / 0162843A, Exp. Date Oct-25; A314 / 4473263A, A314 / 4483263A, A317 / 4493263A, Exp. Date Nov-25; C046 / 0100594A, C047 / 0110594A C050 / 0120594A, Exp. Date Feb-26; C068 / 2770774A, C071 / 2790774A, Exp. Date Mar-26;  C102 / 9621154A, C102 / 9621154B, C102 / 9621154C, Exp. Date Apr-26; C144 / 4721534A,  C144 / 4731534A, C144 / 4741534A, C144 / 4751534A, Exp. Date May-26  b) UPC 813277019930 Lot #: A033 / 5830343A, Exp. Date Feb-25; A079 / 9620893A, A079 / 9630893A, Exp. Date Mar-25; A142 / 3881453A, A142 / 3891453A, Exp. Date May-25", "more_code_info": ""}, {"status": "Ongoing", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["38f67256-77a9-0598-e063-6294a90a9d2d"], "spl_set_id": ["85291b2b-40b9-07fa-e053-2a91aa0a84e4"], "package_ndc": ["54365-400-31"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "96262", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-0259-2025", "product_description": "BD ChloraPrep Clear 1mL Applicators, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile Solution, 0.03 fl. oz (1 mL) each, 60 Applicators per Carton, CareFusion 213, LLC, El Paso, TX 79912, Subsidiary of Becton, Dickinson and Co., REF 930480, NDC 54365-400-31.", "product_quantity": "205,440 applicators", "reason_for_recall": "Non-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.", "recall_initiation_date": "20250214", "center_classification_date": "20250307", "report_date": "20250319", "code_info": "Lot #: 3200240, Exp 6/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96427", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "N/A", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0277-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99", "product_quantity": "1223 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20250305", "center_classification_date": "20250314", "report_date": "20250326", "code_info": "Lot #: DTB23111A, Exp 8/31/2025"}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0265-2025", "product_description": "Voriconazole Container Description: voriconazole\tThe product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.", "product_quantity": "4.0 kg", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Number: HAVZC0020922, exp. date AUG-2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215037"], "brand_name": ["NELARABINE"], "generic_name": ["NELARABINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1726"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NELARABINE"], "rxcui": ["603566"], "spl_id": ["b3627acf-0207-443a-8e5a-0b4ad974715a"], "spl_set_id": ["e425731e-626b-4141-a997-fb85e077c2a4"], "package_ndc": ["70710-1726-1", "70710-1726-8"], "is_original_packager": [true], "upc": ["0370710172619"], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["60158CV180"]}, "product_type": "Drugs", "event_id": "96291", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0255-2025", "product_description": "Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1726-1;  b) 6 x 50 mL Single-Dose Vial, NDC 70710-1726-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ", "product_quantity": "36,978 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250213", "center_classification_date": "20250306", "report_date": "20250312", "code_info": "Lot: a) P300072, P300073 Exp. Feb-2025; P300153, Exp. Jun-25; P300195, Exp. Aug-2025; P400014, P400017, Exp. Dec-2025; P400070, Exp. Feb-2026; P400112, May-2026; P400142, Exp. Jul-2026; b) P300068, Exp. Feb-2025; P300154, Exp.Jun-2025; P400015, P400018, Exp. Dec-2025; P400068, Exp. Feb-2026; P400114, Exp. May-2026; P400139, Exp.Jul-2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0241-2025", "product_description": "Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-758-01.", "product_quantity": "233,040 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19232540, 19232524, 19232553, Exp.: 5/2025; 19240510, Exp.: 1/2026; 19241489, Exp.: 3/2026; 19243905, 19243935, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200770"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-327"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905225"], "spl_id": ["29ba565b-f079-8375-e063-6394a90a83be"], "spl_set_id": ["b9117e55-9fd0-4ba2-94b4-f5f8c522d70c"], "package_ndc": ["63739-327-10", "0000127312", "0000127576", "0000127577", "0000128204", "0000128358"], "original_packager_product_ndc": ["64380-734"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "96159", "recalling_firm": "SKY PACKAGING", "address_1": "4835 Crumpler Rd Ste B", "address_2": "", "postal_code": "38141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0219-2025", "product_description": "HydrALAZINE Hydrochloride, 25 mg, 100 Unit Dose Tablets (10x10), USP, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-327-10", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250124", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot #: 0000127312, Exp. Date 31-Mar-2025; 0000127576, 0000127577, Exp. Date 31-Jul-2025; 0000128204, Exp. Date 31-Dec-2025; 0000128358, Exp. Date 31-Jan-2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214019"], "brand_name": ["DAPSONE"], "generic_name": ["DAPSONE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DAPSONE"], "rxcui": ["1741905"], "spl_id": ["fbed711e-945e-46aa-8883-fee0b7604485"], "spl_set_id": ["30867c69-cf3c-4360-8e56-db96e0b0c3ab"], "package_ndc": ["72578-094-01", "72578-094-02", "72578-094-03"], "is_original_packager": [true], "nui": ["N0000175881", "M0020791"], "pharm_class_epc": ["Sulfone [EPC]"], "pharm_class_cs": ["Sulfones [CS]"], "unii": ["8W5C518302"]}, "product_type": "Drugs", "event_id": "95930", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0171-2025", "product_description": "Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.  packaged in an Airless pump pack", "product_quantity": "23304 packs", "reason_for_recall": "Crystallization", "recall_initiation_date": "20241210", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0158-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08", "product_quantity": "1,815 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lots, expiry: Lot DT6022166A, exp 11/30/2024; Lot DT6023071A, exp 2/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "96196", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one (1) Us Distributor in NJ", "recall_number": "D-0214-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.", "product_quantity": "118104 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20250123", "center_classification_date": "20250131", "report_date": "20250212", "code_info": "Lot#: 083J033, Exp. Date 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M018"], "brand_name": ["POLYVINYL ALCOHOL"], "generic_name": ["POLYVINYL ALCOHOL"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-678"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYVINYL ALCOHOL"], "rxcui": ["142004"], "spl_id": ["334b3c0f-7061-b4b8-e063-6394a90aee9a"], "spl_set_id": ["f18b61da-4033-341a-e053-2a95a90a8ebf"], "package_ndc": ["50268-678-15"], "is_original_packager": [true], "unii": ["532B59J990"]}, "product_type": "Drugs", "event_id": "96032", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0176-2025", "product_description": "Polyvinyl Alcohol Ophthalmic Solution 1.4%, Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-678-15", "product_quantity": "0", "reason_for_recall": "LABELING: LABEL MIX-UP", "recall_initiation_date": "20241218", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lot #: 0160, Exp. Date April 26 2026", "more_code_info": ""}]